Government Law
Viewpoints
Filter by:
New Levine Act Regulations – How Will They Affect You?
June 28, 2023 | Advisory | By Elissa Flynn-Poppey, Michael P. Molstad
Read about regulations interpreting Gov. Code Section 84308 of the Political Reform Act, known as the Levine Act, adopted by the California Fair Political Practices Commission on June 15, 2023.
State Securities Regulators Renew Warnings of COVID-19 Investment Scams
April 17, 2020 | Blog
Several State Securities Regulators continue to warn investors of investment scams involving COVID-19.
Read more
HPC Weighs in on Impact of Question 1
November 1, 2018 | Advisory | By Elissa Flynn-Poppey, Cassandra Paolillo, Stephen Weiner
This article discusses a Massachusetts Health Policy Commission report on the impact of Questions 1, the proposed Nurse Staffing Ratio Mandate.
Read more
Massachusetts Legislature Overhauls Public Records Law
June 3, 2016 | Alert | By Elissa Flynn-Poppey
Last week the Massachusetts Legislature adopted significant changes to the Massachusetts Public Records Law. These changes apply to all state agencies and municipalities and in theory are designed to improve the disclosure of public records in the Commonwealth. The Governor signed the bill into law earlier today.
Read more
Mandatory Privacy Training Rule for Federal Contractors Expected Soon
November 10, 2014 | Alert | By Jonathan T. Cain
A rule to require federal contactors handling personally identifiable information to train their employees in safeguarding the information is close to release.
Read more
VETS-100 and 100A Veteran Hiring Reports Retired by the Department of Labor
September 25, 2014 | Alert | By Jonathan T. Cain
The Department of Labor published a final regulation on September 25, 2014 that relieves federal contractors from filing VETS-100 and VETS-100A veterans hiring reports after 2014. The rules that required the VETS-100 Report have been rescinded.
Read more
Federal District Court Orders FDA to Produce Records Regarding New Drug Application Pursuant to FOIA
August 23, 2014 | Alert | By Kelly Frey, Elissa Flynn-Poppey
Sponsors of developmental new drugs may want to take additional steps to protect their trade secrets and confidential information in the wake of a recent federal court decision narrowly interpreting certain exemptions to the Freedom of Information Act (“FOIA”).
Read more
Labor Department Adds Gender Identity and Transgender Status to Prohibition on Sex Discrimination
August 20, 2014 | Alert | By Jonathan T. Cain
On August 19, 2014, the Department of Labor issued a guidance advising that it will consider cases of discrimination based upon gender identity and transgender status to be violations of Title VII of the Civil Rights Act and Executive Order 11246 (which prohibits employment discrimination by federal contractors).
Read more
Supreme Court Rewrites the Rules for Individual Campaign Contributions: McCutcheon v. Federal Election Commission
April 8, 2014 | Alert | By Elissa Flynn-Poppey, Kelly Frey
On April 2, 2014, the Supreme Court of the United States rendered the McCutcheon decision, addressing the facial validity of Section 203 of the Bipartisan Campaign Reform Act of 2002 (the “BCRA”).
Read more
Explore Other Viewpoints:
- AI: The Washington Report
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Cannabis
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Corporate Governance (ESG)
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- Energy & Sustainability
- Environmental (ESG)
- Environmental Enforcement Defense
- Environmental Law
- Environmental, Social, and Corporate Governance (ESG)
- FDA Regulatory
- False Claims Act
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Impacts of a New US Administration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Probate & Fiduciary Litigation
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Social (ESG)
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- State Attorneys General
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology